Skip to main content
Fig. 4 | European Journal of Medical Research

Fig. 4

From: Network pharmacology and molecular docking analysis on Shenfu Qiangxin indicate mTOR is a potential target to treat heart failure

Fig. 4

Molecular docking. A Original crystal structure of the mTOR downloaded from Protein Data Bank (4JSV); B the monomer structure of mTOR; C the structure of mTOR with each domain marked by different colour; molecular docking for mTOR with moracin D (D), cerevisterol (E), (22e,24r)-ergosta-6-en-3beta,5alpha,6beta-triol (F), deoxyandrographolide (G), moracin O (H) and polyporusterone E (I), on the top shows the surface of the receptor protein and 3D structure of the ligand, at the bottom shows the detail binding bond of each ligand with receptor protein

Back to article page